This website uses cookies to improve your experience. Continue if you are OK with this or read more in our privacy policy. 

AstraZeneca wins Crestor ruling


AstraZeneca wins Crestor ruling

UK pharmaceutical company AstraZeneca has won an appeal court ruling to block the sale of generic versions of its cholesterol medicine Crestor in the US until July 2016.

AstraZeneca, Crestor, ruling, generics, inequitable conduct


Payment types accepted